SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 /EINPresswire.com/ — New global initiative urges patients and clinicians to wait for biomarker testing results ...
Colorectal cancer (CRC) remains one of the most prevalent malignancies and a leading cause of cancer-related mortality worldwide. Beyond tumor-intrinsic ...
Region-specific biomarkers FGFR4, FLT1, and WNT5A are linked to tumor behavior and therapeutic response in CRC. Comprehensive genomic profiling (CGP) aids in precision medicine by identifying genetic ...
New global initiative urges patients and clinicians to wait for biomarker testing results before starting treatment. SAN FRANCISCO, CA, UNITED STATES, January 8, 2026 ...